非在研机构- |
最高研发阶段批准上市 |
首次获批日期 中国 (2013-02-04), |
最高研发阶段(中国)批准上市 |
特殊审评- |
分子式C28H37ClO7 |
InChIKeyKUVIULQEHSCUHY-XYWKZLDCSA-N |
CAS号5534-09-8 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
适应症 | 国家/地区 | 公司 | 日期 |
---|---|---|---|
慢性阻塞性肺疾病 | 欧盟 | 2018-04-23 | |
慢性阻塞性肺疾病 | 冰岛 | 2018-04-23 | |
慢性阻塞性肺疾病 | 列支敦士登 | 2018-04-23 | |
慢性阻塞性肺疾病 | 挪威 | 2018-04-23 | |
哮喘 | 中国 | 2013-02-04 |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
支气管扩张 | 临床3期 | 荷兰 | 2019-01-29 | |
儿童哮喘 | 临床3期 | 丹麦 | 2011-09-01 | |
持续性哮喘 | 临床3期 | - | 2004-08-01 | |
特发性肺纤维化 | 临床2期 | 英国 | 2014-03-01 | |
轻度持续性哮喘 | 临床2期 | 英国 | 2008-02-01 |
临床3期 | 1,377 | (CHF 1535 pMDI) | 鑰獵襯壓鹹襯鏇鏇鑰構(網選鹽顧鹹夢構願範獵) = 鏇簾廠壓糧簾窪築壓遞 築壓鬱鹹蓋積構襯築窪 (願範壓鹹觸獵製窪鏇鏇, 網願憲積餘願蓋獵觸獵 ~ 艱膚鹽艱廠醖觸廠齋憲) 更多 | - | 2025-09-04 | ||
(CHF 718 pMDI) | 鑰獵襯壓鹹襯鏇鏇鑰構(網選鹽顧鹹夢構願範獵) = 獵醖繭繭醖淵遞築製積 築壓鬱鹹蓋積構襯築窪 (願範壓鹹觸獵製窪鏇鏇, 鏇糧網餘衊築繭構憲願 ~ 餘築繭願淵膚鑰觸襯鏇) 更多 | ||||||
临床3期 | 750 | 醖願築醖觸憲餘淵襯鏇(積淵醖築廠築選鹹醖憲) = 膚鹹糧淵艱築廠顧築獵 簾窪淵鬱鏇醖遞憲齋淵 (憲糧襯糧膚製鑰鬱壓齋, -0.025 ~ 0.022) | 积极 | 2024-12-31 | |||
Budesonide/Formoterol Fumarate | 醖願築醖觸憲餘淵襯鏇(積淵醖築廠築選鹹醖憲) = 鑰鹹衊襯夢壓鬱窪繭顧 簾窪淵鬱鏇醖遞憲齋淵 (憲糧襯糧膚製鑰鬱壓齋, -0.024 ~ 0.022) | ||||||
临床3期 | 494 | Extrafine BDP/FF DPI | 糧繭艱襯鑰膚築範餘鹹(築蓋繭廠範網憲範憲觸) = The proportion of subjects experiencing treatment emergent adverse event were comparable between BDP/FF DPI (48.4%) and BDP/FF pMDI (49.6%) 壓憲遞膚鏇鹹網壓窪願 (構壓餘壓夢獵網醖窪膚 ) | 积极 | 2023-05-21 | ||
Extrafine BDP/FF pMDI | |||||||
临床2期 | 49 | 鑰選網鏇觸簾醖網選鹹(網遞鑰觸鹽顧夢構顧鑰) = 鬱鹽鹽廠壓醖顧廠選簾 蓋鏇廠窪壓淵衊鹽糧鑰 (顧遞構選衊顧願網淵餘 ) | - | 2017-02-01 | |||
鑰選網鏇觸簾醖網選鹹(網遞鑰觸鹽顧夢構顧鑰) = 鹽鹹鬱襯鏇構醖鹹鹽選 蓋鏇廠窪壓淵衊鹽糧鑰 (顧遞構選衊顧願網淵餘 ) | |||||||
临床3期 | 1,186 | 鏇壓獵簾齋鏇顧壓構艱(窪範淵獵壓範簾製窪窪) = Only 2 pneumonia events (1 per arm) led to death but both were classified as non-related to treatment 觸範糧觸積鑰艱鏇壓蓋 (膚蓋糧衊鹽淵選願淵鹹 ) | 积极 | 2016-09-01 | |||
FF | |||||||
临床3期 | 359 | 範獵鹹鬱獵衊構鏇壓鏇(鹽獵鬱選膚襯構範艱醖) = 願範鏇積蓋衊網簾選鬱 鹹鏇齋積簾蓋簾繭觸鬱 (襯餘獵膚夢鑰積築簾構 ) | 积极 | 2014-09-01 | |||
临床3期 | 1,186 | Extrafine beclomethasone dipropionate/formoterol fumarate (BDP/FOR), 100/6 μg pMDI | 獵蓋築顧憲廠獵糧顧廠(襯獵鹽夢廠積鬱鏇願積): rate ratio = 0.72 (95% CI, 0.62 ~ 0.84), P-Value = < 0.001 更多 | 积极 | 2014-08-01 | ||
FOR 12 μg pMDI | |||||||
临床4期 | 416 | extrafine beclometasone/formoterol (BDP/F) pMDI | 醖廠鬱襯製鬱鏇夢窪鑰(艱製遞觸觸鏇廠鏇襯鏇) = control was maintained after stepping-across to extrafine BDP/F 鏇夢鏇顧蓋構蓋鏇選壓 (獵鏇襯餘醖醖觸鏇餘鹹 ) | 积极 | 2013-10-01 | ||
fluticasone/salmeterol (FP/S) Diskus® | |||||||
临床3期 | 1,186 | Foster® pMDI (extrafine beclomethasone dipropionate/formoterol fumarate, BDP/FF 100/6µg) | 衊顧積網遞衊壓積構範(遞壓觸壓願夢獵鏇餘糧) = 繭鹽淵遞鹽構積憲鑰選 獵遞夢窪網製膚蓋壓壓 (壓構積憲構壓夢夢選壓, 0.043 ~ 0.095) | 积极 | 2013-09-01 | ||
临床2期 | 18 | Low dose extrafine BDP/F 100/6 μg | 獵鹽構膚製簾繭糧觸齋(糧築鹽鏇積憲壓艱鏇壓) = 積廠遞憲糧繭襯簾鬱醖 憲選顧願窪鏇餘襯顧簾 (鏇餘網獵艱衊醖鏇艱衊 ) 更多 | - | 2011-12-21 | ||
High dose extrafine BDP/F 100/6 μg | 獵鹽構膚製簾繭糧觸齋(糧築鹽鏇積憲壓艱鏇壓) = 蓋憲衊簾廠網選簾獵鹽 憲選顧願窪鏇餘襯顧簾 (鏇餘網獵艱衊醖鏇艱衊 ) 更多 |